Immunocore Holdings plc Interest Received Classified As Investing Activities
Immunocore Holdings plc (IMCR) reported Interest Received Classified As Investing Activities of GBP 5.55 million for the 6-month period ending 2023-06-30, per its 6-K filed 2023-08-10.
Discontinued › Cash Flow › Investing Activities
ifrs-full:InterestReceivedClassifiedAsInvestingActivities · last filed 2023-08-10
| Period end | Interest Received Classified As Investing Activities 6 month | Interest Received Classified As Investing Activities 12 month |
|---|---|---|
| 2023-06-30 | 5.55M GBP 6-K · filed 2023-08-10 | |
| 2022-06-30 | 128.00K GBP 6-K · filed 2023-08-10 | |
| 2021-12-31 | 15.00K GBP 20-F · filed 2022-03-03 | |
| 2020-12-31 | 676.00K GBP 20-F · filed 2022-03-03 | |
| 2019-12-31 | 1.52M GBP 20-F · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |